St. Jude Medical, Atrial Fibrillation Division, Inc.
United Statesfrom the FDA registration address FDA establishment FEI 1000139754
- Devices
- 0
- Registrations
- FDA
- FDA recalls
- 21 ongoing
Company details
- FDA FEI number
- 1000139754
- Address
- One St. Jude Medical Drive, Saint Paul, MN, 55117
FDA recalls
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 0
- 2022 0
- 2023 1
- 2024 0
- 2025 0
- 2026 0
2023
- 18 Dec 2023 Z-0814-2024 Class II Ongoing When the catheters are used with the EnSiteX EP System, the system does not correctly recognize the catheter as the appropriate product model and instead reads and displays it as a different model. This results in some features specific to the catheter do not appear on the display and the catheter image may also appear inverted.
Full distribution text
- 18 Dec 2023 Z-0814-2024 Class II Ongoing When the catheters are used with the EnSiteX EP System, the system does not correctly recognize the catheter as the appropriate product model and instead reads and displays it as a different model. This results in some features specific to the catheter do not appear on the display and the catheter image may also appear inverted.
2009
- 15 Jun 2009 Z-1780-2010 Unclassified (pre-2012) Terminated The firm states that overheating of cardiac tissue is caused by inadequate cooling. The potential exists when the UltraWand is run using off-label cooling methods (gravity saline flow instead of pump) that cooling flow to one or both cells can be decreased based on pressure applied by the physician to the device. To reflect this information to the user, the Atrial Fibrillation Division (AFD) has
Full distribution text
- 15 Jun 2009 Z-1780-2010 Unclassified (pre-2012) Terminated The firm states that overheating of cardiac tissue is caused by inadequate cooling. The potential exists when the UltraWand is run using off-label cooling methods (gravity saline flow instead of pump) that cooling flow to one or both cells can be decreased based on pressure applied by the physician to the device. To reflect this information to the user, the Atrial Fibrillation Division (AFD) has